← Leaderboards
Quasar S Padiath
University Of Pittsburgh At Pittsburgh
$5,958,511
Attributed
$6,545,074
Total exposure
8
Grants
6
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.4M · FY2013–25$2M$1.5M$1M$500K$0
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$6,545,074 · 8
By mechanism
R01$3,417,735 · 2
R21$1,597,247 · 4
R33$1,530,092 · 2
Top collaborators
- Andreas Vogt3 shared
Most similar at University Of Pittsburgh At Pittsburgh
Same institution · by research overlap
- Andreas Vogt$5,634,005
- Michael John Palladino$10,111,937
- Da Yang$5,984,718
- Robert D Nicholls$6,020,455
- Xinyan Tracy Cui$15,273,948
Others in their field
Top investigators on “Nuclear”
- David W Simpson · University Of Southern California$143,628,960
- Polly Chang · Sri International$113,805,005
- Gregory S Boebinger · Florida State University$83,575,927
- Charles H Mielke · Florida State University$82,175,927
- Alan G Marshall · Florida State University$82,175,927
- Gaetano T Montelione · Rutgers The St Univ Of Nj New Brunswick$74,984,787
Research focus
NuclearProteinsLamin B1OligodendrogliaPhenotypeLeukodystrophyDemyelinationsNuclear LaminaDemyelinating DiseasesChromatinMouse ModelAdultGene ExpressionOverexpressionCessation Of LifeArchitecturePlayGenesNuclear Inner MembraneOnset Of IllnessMediatingDisease PhenotypeMotor DisorderLmnb1 Gene
Grant awards (21)
Elucidating Regulatory Mechanisms of Lamin B1 Expression in Autosomal Dominant Leukodystrophy$418,896
R01 · FY2025 · NS · contact PI
Elucidating Regulatory Mechanisms of Lamin B1 Expression in Autosomal Dominant Leukodystrophy$439,772
R01 · FY2024 · NS · contact PI
Modulating Lamin B1 levels as a therapeutic strategy for Autosomal Dominant Leukodystrophy$228,465
R21 · FY2024 · NS · contact PI
Elucidating Regulatory Mechanisms of Lamin B1 Expression in Autosomal Dominant Leukodystrophy$406,143
R01 · FY2023 · NS · contact PI
Modulating Lamin B1 levels as a therapeutic strategy for Autosomal Dominant Leukodystrophy$190,490
R21 · FY2023 · NS · contact PI
Elucidating Regulatory Mechanisms of Lamin B1 Expression in Autosomal Dominant Leukodystrophy$40,834
R01 · FY2023 · NS · contact PI
Exploring Antisense Oligonucleotides as a potential therapy for Autosomal Dominant Leukodystrophy$373,796
R33 · FY2021 · NS · contact PI
High-content screening for modulators of lamin B1 as a therapeutic target in autosomal dominant leukodystrophy$391,250
R33 · FY2020 · NS
Exploring Antisense Oligonucleotides as a potential therapy for Autosomal Dominant Leukodystrophy$373,796
R33 · FY2020 · NS · contact PI
Elucidating mechanisms involved in Lamin B1 mediated demyelination$336,875
R01 · FY2020 · NS · contact PI
Alzheimer's-Focused Administrative Supplement$248,970
R01 · FY2020 · NS · contact PI
High-content screening for modulators of lamin B1 as a therapeutic target in autosomal dominant leukodystrophy$391,250
R33 · FY2019 · NS
Elucidating mechanisms involved in Lamin B1 mediated demyelination$345,972
R01 · FY2019 · NS · contact PI
Elucidating mechanisms involved in Lamin B1 mediated demyelination$392,834
R01 · FY2018 · NS · contact PI
High-content screening for modulators of lamin B1 as a therapeutic target in autosomal dominant leukodystrophy$390,626
R21 · FY2018 · NS
Exploring Antisense Oligonucleotides as a potential therapy for Autosomal Dominant Leukodystrophy$353,208
R21 · FY2018 · NS · contact PI
Elucidating mechanisms involved in Lamin B1 mediated demyelination$395,197
R01 · FY2017 · NS · contact PI
Elucidating mechanisms involved in Lamin B1 mediated demyelination$345,380
R01 · FY2016 · NS · contact PI
Elucidating mechanisms involved in Lamin B1 mediated demyelination$46,862
R01 · FY2016 · NS · contact PI
Studying the role of the nuclear lamina in age dependent demyelination$191,388
R21 · FY2014 · AG · contact PI
Studying the role of the nuclear lamina in age dependent demyelination$243,070
R21 · FY2013 · AG · contact PI